Brief: Tscan Therapeutics Announces CEO Transition
31/03/2023 13:13
TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ANNOUNCES CEO TRANSITION
* TSCAN THERAPEUTICS INC - DAVID SOUTHWELL STEPS DOWN AS CEO
* TSCAN THERAPEUTICS INC - DAVID SOUTHWELL STEPS DOWN; GAVIN
MACBEATH TO SERVE AS ACTING CEO
* TSCAN THERAPEUTICS INC - REAFFIRMS PREVIOUSLY DISCLOSED
MILESTONES AND CASH RUNWAY; PROVIDES CLINICAL PROGRAM UPDATE
* TSCAN THERAPEUTICS INC - COMPANY REAFFIRMS PREVIOUSLY
DISCLOSED
MILESTONES AND CASH RUNWAY
Source text for Eikon: ID:nGNX1yTqWG
Further company coverage: TCRX.O
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing